{"id":"W4402130678","doi":"10.1093/eurheartj/ehae596","title":"Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials","year":2024,"lang":"en","type":"review","venue":"European Heart Journal","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal Heart Institute; University of Ottawa; Impact; McMaster University; Université de Montréal; Population Health Research Institute","funders":"Medical Research Council; Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; St. Jude Medical; Bayer Canada; National Institutes of Health; Daiichi Sankyo Europe; HORIZON EUROPE Framework Programme; Servier; Vifor Pharma; Deutsche Herzstiftung; Novo Nordisk; Fondation Leducq; British Heart Foundation; Daiichi-Sankyo; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; MicroPort; Impulse Dynamics; ZOLL Medical Corporation; Amgen; European Society of Cardiology; Stockholms Läns Landsting; Hamilton Health Sciences; Boston Scientific Corporation; Biogen; Pfizer; Daiichi Sankyo Company; Heart and Stroke Foundation of Canada; European Commission; GlaxoSmithKline; Deutsches Zentrum für Herz-Kreislaufforschung; Universität Hamburg; Sanofi; Kompetenznetz Vorhofflimmern; Deutsche Forschungsgemeinschaft; Population Health Research Institute; Bayer Vital; Bristol-Myers Squibb; AstraZeneca","keywords":"Medicine; Atrial fibrillation; Cardiology; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01263324,0.00121799,0.005875994,0.000938196,0.0003338779,0.002234185,0.0006504959,0.001322596,0.003213738],"category_scores_gemma":[0.01573406,0.0004282374,0.01114445,0.001407194,0.0004888868,0.001263771,0.000974611,0.001821377,0.0002939297],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005907369,"about_ca_system_score_gemma":0.0008286309,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008013085,"about_ca_topic_score_gemma":0.003564643,"domain_scores_codex":[0.986246,0.01004062,0.001500117,0.0009642552,0.000898726,0.0003503771],"domain_scores_gemma":[0.980227,0.01282059,0.004057884,0.001111791,0.001011843,0.0007708397],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.6968581,0.000409658,0.0304933,0.01875812,0.2072006,0.0003058618,0.0001350879,0.001286946,0.002114508,0.0006647389,0.003288615,0.03848443],"study_design_scores_gemma":[0.3573474,0.02639253,0.1227676,0.003111084,0.4737183,0.000864789,0.0001858145,0.00175199,0.001123436,0.001603289,0.01094754,0.0001862823],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.701844,0.2813307,0.001640165,0.002278458,0.0008263178,0.0008565257,0.005788384,0.00009040225,0.005344912],"genre_scores_gemma":[0.9655671,0.02578559,0.001328549,0.001003118,0.0007160155,0.0006042029,0.0040238,0.0000280074,0.0009436192],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.01263324,"threshold_uncertainty_score":0.0668118,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1860807184182054,"score_gpt":0.4189414326730618,"score_spread":0.2328607142548565,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}